The U.S. Food and Drug Administration has sent a warning letter to Marlborough, Mass.-based medical technology company ...
FDA issues warning to Hologic, citing manufacturing and safety violations for BioZorb devices. Patient safety risks and reporting failures highlighted ...
Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.
Hologic Inc. has received a warning letter from the Food and Drug Administration regarding its BioZorb product line, even ...